• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"

    1/2/26 6:30:00 AM ET
    $ACH
    Medical Specialities
    Health Care
    Get the next $ACH alert in real time by email

    Accendra Health, Inc. (NYSE:ACH) (the "Company") announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, "ACH", effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand.

    Safe Harbor

    This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain "forward looking" statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the statements in this release regarding our future prospects and performance, including our expectations with respect to our financial performance, our 2025 financial results, our expectations regarding the performance of our business following the completion of the sale of the Products & Healthcare Services business, our cost saving initiatives, future indebtedness and growth, industry trends, as well as statements related to our expectations regarding the performance of our business, including our ability to address macro and market conditions. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 28, 2025, including the section captioned "Item 1A. Risk Factors," as applicable, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the Company's actual results to differ materially from its current estimates. These filings are available at www.accendrahealth.com. Given these risks and uncertainties, The Company can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, cautions investors not to place undue reliance on them. The Company specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

    About Accendra Health, Inc.

    Accendra Health, Inc. (NYSE:ACH) is a leading nationwide provider of products, technology and services that support health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology and ostomy, visit www.accendrahealth.com.

    ACH-CORP

    ACH-IR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260102331480/en/

    Investors

    Will Parrish

    Vice President | Strategy, Corporate Development, & Investor Relations

    [email protected]

    Media

    Darla Turner

    [email protected]

    Get the next $ACH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACH

    DatePrice TargetRatingAnalyst
    8/25/2022Sell → Neutral
    Goldman
    3/23/2022Reduce → Hold
    HSBC Securities
    More analyst ratings

    $ACH
    SEC Filings

    View All

    SEC Form 10-K filed by Accendra Health Inc.

    10-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    2/20/26 4:19:33 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    2/19/26 4:10:24 PM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 15F-12B filed by Aluminum Corporation of China Limited

    15F-12B - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)

    2/2/24 6:02:12 AM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"

    Accendra Health, Inc. (NYSE:ACH) (the "Company") announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, "ACH", effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain "forward looking" s

    1/2/26 6:30:00 AM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alum. Corp China upgraded by Goldman

    Goldman upgraded Alum. Corp China from Sell to Neutral

    8/25/22 1:04:06 PM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by HSBC Securities

    HSBC Securities upgraded Alum. Corp China from Reduce to Hold

    3/23/22 7:04:02 AM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by JP Morgan

    JP Morgan upgraded Alum. Corp China from Neutral to Overweight

    4/8/21 12:27:37 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Financials

    Live finance-specific insights

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - ALUMINUM CORP OF CHINA LTD (0001161611) (Subject)

    2/16/21 3:46:32 PM ET
    $ACH
    Medical Specialities
    Health Care